Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean

The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a signifi...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2008
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23449
Acceso en línea:
https://doi.org/10.1016/j.vaccine.2008.06.008
https://repository.urosario.edu.co/handle/10336/23449
Palabra clave:
Antiretrovirus agent
Oral contraceptive agent
Virus dna
Wart virus vaccine
Acquired immune deficiency syndrome
Article
Cancer incidence
Cancer mortality
Cancer prevention
Cancer risk
Cancer screening
Caribbean islands
Chlamydia trachomatis
Cigarette smoking
Comorbidity
Disease association
Disease course
Herpes simplex virus 2
Human
Human immunodeficiency virus infection
Human papillomavirus type 16
Human papillomavirus type 18
Nonhuman
Oral contraception
Parity
Polymerase chain reaction
Priority journal
Risk assessment
Risk factor
Sexual behavior
Sexual transmission
South and central america
Uterine cervix cancer
Virus infection
Virus transmission
Wart virus
Caribbean
Cervical cancer
Hpv
Hpv variants
Latin america
Male sexual behaviour
Risk factors
Sexual behaviour
Rights
License
Abierto (Texto Completo)
id EDOCUR2_8c861ca5378dd7abf98dc0bfec43a681
oai_identifier_str oai:repository.urosario.edu.co:10336/23449
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling db5cb0fc-18cb-4d69-8ae6-be1eecc6f4d3-12fff3067-d041-4766-a012-25955c064690-1cef33379-d6e1-4bd7-88f4-744459452ed2-1b552851b-29c5-4bf0-adc7-0c46eaf2d19a-1a633856a-e7e7-4d18-b31b-bcea7534db05-16c8bcbd4-74fd-4eb2-9bea-dfa19307ee4b-12020-05-26T00:02:07Z2020-05-26T00:02:07Z2008The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health problem. Overall human papillomavirus (HPV) prevalence in the LAC general population has been found to be 2-fold higher than the average worldwide prevalence. The large HPV and cancer burden may be explained by the highly prevalent HPV variants of HPV types -16 and 18, which have an increased oncogenic potential. Given the major mode of transmission of genital HPV is sexual, certain, patterns of sexual behaviour (early age at first sexual intercourse, number of sexual partners and sexual behaviour of the partner) are associated with an increased risk of HPV genital acquisition. Although HPV infection is necessary for carcinogenesis, certain co-factors (high parity, long term use of oral contraceptives, smoking and co-infection with the human immunodeficiency virus (HIV)) help in the progression from infection to cancer. Many studies that have contributed to this evidence have been carried out in LAC and are reviewed and summarised in this article. Since HPV vaccines will likely take years to implement, and many more years to show impact on disease, cervical cancer screening programmes remain as the key intervention to control disease in LAC in the years to come. © 2008 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.vaccine.2008.06.0080264410X13588745https://repository.urosario.edu.co/handle/10336/23449engElsevier BVL36 No. SUPPL. 11L16VaccineVol. 26Vaccine, ISSN:0264410X, 13588745, Vol.26, No.SUPPL. 11 (2008); pp. L16-L36https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849090008&doi=10.1016%2fj.vaccine.2008.06.008&partnerID=40&md5=7fb321cb7b2588097c5a17b98ed41cddAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAntiretrovirus agentOral contraceptive agentVirus dnaWart virus vaccineAcquired immune deficiency syndromeArticleCancer incidenceCancer mortalityCancer preventionCancer riskCancer screeningCaribbean islandsChlamydia trachomatisCigarette smokingComorbidityDisease associationDisease courseHerpes simplex virus 2HumanHuman immunodeficiency virus infectionHuman papillomavirus type 16Human papillomavirus type 18NonhumanOral contraceptionParityPolymerase chain reactionPriority journalRisk assessmentRisk factorSexual behaviorSexual transmissionSouth and central americaUterine cervix cancerVirus infectionVirus transmissionWart virusCaribbeanCervical cancerHpvHpv variantsLatin americaMale sexual behaviourRisk factorsSexual behaviourRisk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the CaribbeanarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Almonte, MaribelAlbero, GinesaMolano, MónicaCarcamo, CésarGarcía, Patricia J.Pérez, Gonzalo10336/23449oai:repository.urosario.edu.co:10336/234492022-05-02 07:37:14.602964https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
title Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
spellingShingle Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
Antiretrovirus agent
Oral contraceptive agent
Virus dna
Wart virus vaccine
Acquired immune deficiency syndrome
Article
Cancer incidence
Cancer mortality
Cancer prevention
Cancer risk
Cancer screening
Caribbean islands
Chlamydia trachomatis
Cigarette smoking
Comorbidity
Disease association
Disease course
Herpes simplex virus 2
Human
Human immunodeficiency virus infection
Human papillomavirus type 16
Human papillomavirus type 18
Nonhuman
Oral contraception
Parity
Polymerase chain reaction
Priority journal
Risk assessment
Risk factor
Sexual behavior
Sexual transmission
South and central america
Uterine cervix cancer
Virus infection
Virus transmission
Wart virus
Caribbean
Cervical cancer
Hpv
Hpv variants
Latin america
Male sexual behaviour
Risk factors
Sexual behaviour
title_short Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
title_full Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
title_fullStr Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
title_full_unstemmed Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
title_sort Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
dc.subject.keyword.spa.fl_str_mv Antiretrovirus agent
Oral contraceptive agent
Virus dna
Wart virus vaccine
Acquired immune deficiency syndrome
Article
Cancer incidence
Cancer mortality
Cancer prevention
Cancer risk
Cancer screening
Caribbean islands
Chlamydia trachomatis
Cigarette smoking
Comorbidity
Disease association
Disease course
Herpes simplex virus 2
Human
Human immunodeficiency virus infection
Human papillomavirus type 16
Human papillomavirus type 18
Nonhuman
Oral contraception
Parity
Polymerase chain reaction
Priority journal
Risk assessment
Risk factor
Sexual behavior
Sexual transmission
South and central america
Uterine cervix cancer
Virus infection
Virus transmission
Wart virus
Caribbean
Cervical cancer
Hpv
Hpv variants
Latin america
Male sexual behaviour
Risk factors
Sexual behaviour
topic Antiretrovirus agent
Oral contraceptive agent
Virus dna
Wart virus vaccine
Acquired immune deficiency syndrome
Article
Cancer incidence
Cancer mortality
Cancer prevention
Cancer risk
Cancer screening
Caribbean islands
Chlamydia trachomatis
Cigarette smoking
Comorbidity
Disease association
Disease course
Herpes simplex virus 2
Human
Human immunodeficiency virus infection
Human papillomavirus type 16
Human papillomavirus type 18
Nonhuman
Oral contraception
Parity
Polymerase chain reaction
Priority journal
Risk assessment
Risk factor
Sexual behavior
Sexual transmission
South and central america
Uterine cervix cancer
Virus infection
Virus transmission
Wart virus
Caribbean
Cervical cancer
Hpv
Hpv variants
Latin america
Male sexual behaviour
Risk factors
Sexual behaviour
description The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health problem. Overall human papillomavirus (HPV) prevalence in the LAC general population has been found to be 2-fold higher than the average worldwide prevalence. The large HPV and cancer burden may be explained by the highly prevalent HPV variants of HPV types -16 and 18, which have an increased oncogenic potential. Given the major mode of transmission of genital HPV is sexual, certain, patterns of sexual behaviour (early age at first sexual intercourse, number of sexual partners and sexual behaviour of the partner) are associated with an increased risk of HPV genital acquisition. Although HPV infection is necessary for carcinogenesis, certain co-factors (high parity, long term use of oral contraceptives, smoking and co-infection with the human immunodeficiency virus (HIV)) help in the progression from infection to cancer. Many studies that have contributed to this evidence have been carried out in LAC and are reviewed and summarised in this article. Since HPV vaccines will likely take years to implement, and many more years to show impact on disease, cervical cancer screening programmes remain as the key intervention to control disease in LAC in the years to come. © 2008 Elsevier Ltd. All rights reserved.
publishDate 2008
dc.date.created.spa.fl_str_mv 2008
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:07Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:07Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.vaccine.2008.06.008
dc.identifier.issn.none.fl_str_mv 0264410X
13588745
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23449
url https://doi.org/10.1016/j.vaccine.2008.06.008
https://repository.urosario.edu.co/handle/10336/23449
identifier_str_mv 0264410X
13588745
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv L36
dc.relation.citationIssue.none.fl_str_mv No. SUPPL. 11
dc.relation.citationStartPage.none.fl_str_mv L16
dc.relation.citationTitle.none.fl_str_mv Vaccine
dc.relation.citationVolume.none.fl_str_mv Vol. 26
dc.relation.ispartof.spa.fl_str_mv Vaccine, ISSN:0264410X, 13588745, Vol.26, No.SUPPL. 11 (2008); pp. L16-L36
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849090008&doi=10.1016%2fj.vaccine.2008.06.008&partnerID=40&md5=7fb321cb7b2588097c5a17b98ed41cdd
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier BV
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390623025168384